Have a personal or library account? Click to login
Silica nanoparticles in targeted human cancer therapy Cover

Silica nanoparticles in targeted human cancer therapy

Medical Journal of Cell Biology
Volume 10 (2022): Issue 1 (March 2022)
By: Hesham Mohamed Abdal-Salam Yehia,  Said Mahmoud Said and  Noheer Galal Elden Rashad Ragb  
Open Access
|Apr 2022

Authors

Hesham Mohamed Abdal-Salam Yehia

hyehia@hlogicgroup.com

Department of Biotechnology, HST Company, Cairo, Egypt

Said Mahmoud Said

Department of Biotechnology, HST Company, Cairo, Egypt

Noheer Galal Elden Rashad Ragb

Faculty Member at Fayoum University, Fayoum University, Fayoum, Egypt
DOI: https://doi.org/10.2478/acb-2022-0002 | Journal eISSN: 2544-3577
Journal RSS Feed
Language: English
Page range: 7 - 17
Submitted on: Jan 28, 2022
|
Accepted on: Mar 2, 2022
|
Published on: Apr 10, 2022
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Na2SiO3,
human cancer,
antioxidant,
HOMO,
LUMO
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2022 Hesham Mohamed Abdal-Salam Yehia, Said Mahmoud Said, Noheer Galal Elden Rashad Ragb, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 10 (2022): Issue 1 (March 2022)Next article